Insurance vs Investment: Stop Confusing the Two

Every ULIP, every endowment, every money-back plan is sold as "insurance that also grows your money". They do neither well. Typically 1/5th the cover of pure term for the same premium, and 1/2 the return of index SIPs over 20 years. The separation principle solves both: buy term insurance separately, invest separately, never let the two be sold together. The agent commission on combo products is 25-40% of year-1 premium; on pure term it is 2-5%. Follow the incentive structure and you will see why agents push combos relentlessly.

By the end, you will know why the combo is structurally inferior, the three product families to avoid, and the separation math that recovers Rs. 30-80 lakh over a 25-year horizon.

Why combos fail. Four structural drags

Higher premium to more commission to agent (30-40% of year-1 premium in some products; term has 2-5%).
Investment portion has 2-4% annual charges (mortality, fund management, admin) eroding return.
Cover portion is typically 10x annual premium, far below the 15x annual income need for life insurance.
Illiquidity. Lock-in 5-20 years; surrender penalties are steep in early years (30-60% loss).

The agent's incentive structure drives the sale. A Rs. 1 lakh annual premium ULIP pays the agent Rs. 25-40k in year 1. A Rs. 12k pure term pays Rs. 500-600. The same Rs. 2L annual savings, if split into term + MF SIP, nets the agent roughly Rs. 1,200 total. No wonder the combo gets pitched as "financial planning" and the separate path as "too complicated".

The separation principle

Pure term life = Rs. 1 crore cover for Rs. 12k/year (age 30). Index SIP = Rs. 15k/month in a Nifty 500 passive fund. Total: Rs. 1.94 lakh/year. 25-year outcome: Rs. 1 crore life cover throughout + Rs. 1.5-1.7 crore projected equity corpus. ULIP/endowment equivalent at Rs. 2 lakh/year: Rs. 20-30 lakh cover + Rs. 70-90 lakh corpus. The delta over 25 years: Rs. 70-90 lakh wealth + Rs. 70 lakh higher cover. Cumulative Rs. 1.5 crore underperformance across a lifetime of the combo product.

Separation logic also applies to 80C. Both pure term AND ELSS (the SIP equivalent) qualify for 80C under the old regime. You get the tax benefit regardless of whether you buy combo or separate. The tax-benefit "feature" of ULIP is product-neutral; it is not a reason to pick the inferior structure.

Three product families to avoid

ULIPs (Unit-Linked Insurance Plans): 2-4% annual charges, 5-year lock-in, complex switching rules. Marketed as "invested" insurance. Actual returns over 20 years: 5-7% post-charges. Alternatives: term + index fund = 10-12% on the investment portion.

Endowment plans: traditional insurance with guaranteed payout. Returns 4-5% IRR. Lock-in entire term (15-30 years). Surrender values are poor in first 5-10 years. Alternatives: term + debt fund/PPF for guaranteed portion = 7-8% with liquidity.

Money-back plans: periodic partial payouts during term + survival benefit. Return IRR 3-5%. The periodic payouts reduce final corpus and carry insurance-inflated charges. Alternatives: term + systematic withdrawals from growth fund = better yield with flexibility.

The "saved tax" argument is weakest

Combos are often sold as "80C eligible". Pure term is ALSO 80C eligible. ELSS (the SIP equivalent) is ALSO 80C eligible. The tax benefit is a product-neutral feature, not a reason to pick the inferior combo product. Don't let the 80C tail wag the investment-return dog.

The "saved tax" argument is weakest

Combos sold as "80C eligible". So are pure term and ELSS. Tax benefit is product-neutral. Pick the product on investment return; 80C is a side-benefit either way.

If you already hold one

Compare policy IRR (typically 4-5%) against SIP alternative (10-12%). If remaining tenure > 10 years, surrender + SIP usually wins. If nearing maturity (< 5 years), continue to maturity. See endowment-surrender article for detailed math.

The one genuine use case for ULIPs

Ultra-high net worth (UHNI) individuals sometimes buy ULIPs for the Section 10(10D) tax advantage (maturity tax-free if conditions met) and insurance-wrapper legal protection. For sub-Rs. 5 crore portfolios, separation wins. The UHNI case requires Rs. 5L+ annual premium with specific cover structures; retail investors should not optimise for this.

Key Takeaways

Insurance and investment are different problems; solve them separately.
Pure term + index SIP dominates every combo product over 20+ year horizons.
Year-1 combo commissions can exceed 30% of premium (vs 2-5% on term).
Tax benefit applies to both; pick on return, not on 80C.
If you already hold one, see the endowment-surrender article for the decision framework.